NCAPD2 anticorps (C-Term)
Aperçu rapide pour NCAPD2 anticorps (C-Term) (ABIN634129)
Antigène
Voir toutes NCAPD2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- NCAPD2 antibody was raised against the C terminal of NCAPD2
-
Purification
- Affinity purified
-
Immunogène
- NCAPD2 antibody was raised using the C terminal of NCAPD2 corresponding to a region with amino acids KAIIDEFEQKLRACHTRGLDGIKELEIGQAGSQRAPSAKKPSTGSRYQPL
-
-
-
-
Indications d'application
-
WB: 0.5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
NCAPD2 Blocking Peptide, (ABIN939632), is also available for use as a blocking control in assays to test for specificity of this NCAPD2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of NCAPD2 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- NCAPD2 (Non-SMC Condensin I Complex, Subunit D2 (NCAPD2))
-
Autre désignation
- NCAPD2
-
Sujet
- NCAPD2 is the regulatory subunit of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases. NCAPD2 may target the condensin complex to DNA via its C-terminal domain.
-
Poids moléculaire
- 157 kDa (MW of target protein)
Antigène
-